United Health Products, Inc.
UEEC
$0.17
-$0.01-5.56%
| Weiss Ratings | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.26 | |||
| Price History | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.41% | |||
| 30-Day Total Return | 143.55% | |||
| 60-Day Total Return | 135.78% | |||
| 90-Day Total Return | 41.90% | |||
| Year to Date Total Return | 209.09% | |||
| 1-Year Total Return | -2.86% | |||
| 2-Year Total Return | -24.44% | |||
| 3-Year Total Return | -62.22% | |||
| 5-Year Total Return | -75.36% | |||
| 52-Week High % Change | -19.64% | |||
| 52-Week Low % Change | 291.30% | |||
| Price | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.22 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | Dec 13, 2024 | |||
| 52-Week High Price (Date) | Mar 21, 2024 | |||
| Valuation | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 45.16M | |||
| Enterprise Value | 46.03M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -45.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -21.18 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.17 | |||
| Enterprise Value/EBITDA (TTM) | -27.65 | |||
| Enterprise Value/EBIT | -27.58 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 248.61M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 475 755 1005 | |||
| Address | 520 Fellowship Road Mount Laurel, NJ 08054 | |||
| Website | uhpcorp.com | |||
| Country | United States | |||
| Year Founded | 1997 | |||
| Profitability | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -428.98% | |||
| Return on Equity | -- | |||
| Income Statement | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.66M | |||
| EBIT (TTM) | -1.67M | |||
| Net Income (TTM) | -1.66M | |||
| Net Income Avl. to Common (TTM) | -1.66M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 37.47% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 40.00% | |||
| Balance Sheet | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 43.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 63.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.11M | |||
| Current Ratio (Q) | 0.028 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 150.60K | |||
| Total Current Liabilities (Q) | 2.24M | |||
| Total Debt (Q) | 913.60K | |||
| Total Liabilities (Q) | 2.26M | |||
| Total Common Equity (Q) | -2.11M | |||
| Cash Flow | UEEC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 1.56M | |||
| Net Change in Cash (TTM) | -30.20K | |||
| Levered Free Cash Flow (TTM) | -1.04M | |||
| Cash from Operations (TTM) | -1.59M | |||
